Most patients with long-term conditions are performing some form of self-care as opposed to receiving professional care at hospitals. Injectable treatments have become increasingly common in the self-management of a wide range of medical conditions. However, these treatments can be complex and challenging for patients to manage, with potential risks of adverse events and suboptimal treatment outcomes. Digital self-care tools offer a promising solution to these challenges, by providing patients with the means to monitor and manage their treatments more effectively.
In today’s healthcare landscape, pharmaceutical companies have an opportunity to step up to support patients in a more personal way through digital health solutions. The repercussions of subpar self-care management, like therapy drop-offs and low patient engagement, emphasise the urgency to empower individuals in their treatment journeys.
Join other pharmaceutical executives over dinner and brainstorm how digital health technologies can alleviate pressing patient pain points and support business objectives. With your peers dive deep into the following questions:
Please note: This meeting is part of a three-part series of insights roundtables that HealthXL is hosting in collaboration with Ypsomed. Insights from this roundtable will feed into a white paper that HealthXL and Ypsomed will publish later this year. To sign up to participate in a future session, please get in touch with the HealthXL team.














































